SCARB1 and Familial prostate cancer: There is evidence that SR-BI plays a role in prostate cancer development, specific antigen secretion and the viability of prostate cancer cells because it was shown that SR-BI-specific knockdown in LNCaP and C4-2 prostate carcinoma cells reduced PSA secretion and the viability of prostate cancer cell lines [15].